EDGAR Filing Documents for 0001485003-18-000027

Form 8-K - Current report:

SEC Accession No. 0001485003-18-000027

Filing Date

2018-03-23

Accepted

2018-03-23 16:41:50

Documents

Period of Report

2018-03-21

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	ebio-form8xkrdoclosing.htm	8-K	43832
2	EXHIBIT 1.1	exhibit11.htm	EX-1.1	74374
3	EXHIBIT 4.1	exhibit41.htm	EX-4.1	118918
4	EXHIBIT 5.1	exhibit51hoganopinionandco.htm	EX-5.1	12655
5	EXHIBIT 10.1	exhibit101.htm	EX-10.1	399232
6		hoganlogo.jpg	GRAPHIC	28096
	Complete submission text file	0001485003-18-000027.txt		688925

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142

Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550

Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 18710616
SIC: 2834 Pharmaceutical Preparations